Dublin hospital to enter first of its kind clinical trial in 'bespoke' cancer vaccines

The trial is due to start at Tallaght University Hospital in two weeks, and will be conducted using revolutionary messenger RNA biotechnology.

A Dublin hospital is to become one of the first in the world to enter clinical trials for “ground-breaking” personalised cancer vaccines.

The trial is due to start at Tallaght University Hospital in two weeks, and will be conducted using revolutionary messenger RNA (mRNA) biotechnology — which became prominent during the covid pandemic with vaccines.